As of Feb 17
| 0.00 / 0.00%|
The 8 analysts offering 12-month price forecasts for PharMerica Corp have a median target of 28.50, with a high estimate of 35.00 and a low estimate of 19.00. The median estimate represents a +8.37% increase from the last price of 26.30.
The current consensus among 8 polled investment analysts is to Buy stock in PharMerica Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.